An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.
The therapy involves genetically programming cells from the patient’s own immune system to fight the disease.
The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22. All were severely ill, with acute lymphoblastic leukemia, and had relapsed several times or had never responded to typical therapies. In more than half, the disease had come back even after a stem-cell transplant, which usually gives patients the best hope of surviving. Their life expectancy was a few months, or in some cases just weeks.
Six months after being treated, 23 of the 30 patients were still alive, and 19 of them have remained in complete remission.
“We have a number of patients who are a year or more out and are in remission and not requiring other therapies,” said Dr. Stephan A. Grupp, who led the part of the study done at Children’s Hospital of Philadelphia. He said those long remissions gave the researchers hope that the treatment would have lasting effects.
Earlier reports by the same researchers involved only a handful of patients, some with chronic rather than acute leukemia. The scientists say the growing number of patients treated helps demonstrate that the findings are real.
The Latest on: Leukemia
via Google News
The Latest on: Leukemia
- WATCH: 6-year-old boy returns to school greeted with applause, cheers after beating leukemiaon January 12, 2020 at 2:31 am
As a 6-year-old boy enters the new decade cancer-free, his school decided to surprise him with a celebration for the young warrior’s win against leukemia, which he battled for three years.
- Survivors of childhood acute lymphoblastic leukemia at higher risk for type 2 diabeteson January 9, 2020 at 11:53 am
Survivors of childhood acute lymphoblastic leukemia, particularly those with obesity and/or who received treatment during adolescence, appeared to be at higher risk for type 2 diabetes than the ...
- FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questionson January 9, 2020 at 9:05 am
The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately one third of patients with acute myeloid leukemia (AML), either by internal tandem duplications (FLT3-ITD), or by a point ...
- Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansionon January 9, 2020 at 7:26 am
CAR-T-cell therapy has shown considerable advance in recent years, being approved by regulatory agencies in US, Europe, and Japan for the treatment of refractory patients with CD19+ B-cell leukemia or ...
- 6-year-old Ohio boy beats leukemia; classmates celebrate final chemo treatmenton January 9, 2020 at 5:32 am
John Oliver Zipay, also known as J.O., received his final round of chemotherapy two days after Christmas, ending a 3-year battle with leukemia. So Wednesday, his classmates, teachers and family took ...
- Leukemia Therapeutics Market 2020 Global Trends, Industry Share, Supply, Demand, Size, Growth and Forecast to 2025|MRE Analysison January 9, 2020 at 4:32 am
New York, January 09, 2020: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled ...
- High school holds special graduation ceremony for student battling leukemiaon January 8, 2020 at 3:45 pm
(KMOV.com) – Holt High School recently held a special ceremony for 17-year-old Sullivan Menne. Mene, who goes by "Sulley," was diagnosed with leukemia when he was 15. Three weeks ago, his family ...
- Funeral on Thursday for Boca fire captain felled by leukemiaon January 8, 2020 at 10:08 am
BOCA RATON - Fellow firefighters Thursday will honor Boca Raton Fire Rescue Capt. Michael Eugene Francis, who died Dec. 31 at age 51 from complications of leukemia. A funeral is set for 10 a.m.
- Acute Lymphoblastic Leukemia Treatment Market(CAGR of 5.5%)- Industry Trends, Research Methodology, Renewable Resource, Market Research, 2027on January 7, 2020 at 8:06 pm
Research Nester released a report titled "Acute Lymphoblastic Leukemia Treatment Market: Global Demand Analysis & Opportunity Outlook 2027"which delivers detailed overview of the global acute ...
- Burlington Stores Raises More Than $5.8 Million For The Leukemia & Lymphoma Society This Yearon January 7, 2020 at 5:00 am
via Bing News